Center-Authored Papers

Filters: Author is Martin, Paul J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Young Adult
Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ et al..  2014.  Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.. Blood. 124(22):3221-7;quiz3335. Abstract
Martin PJ, Counts GW, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ, Flowers MED, Syrjala KL, Hansen JA, Storb R et al..  2010.  Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(6):1011-6. Abstract
Rotta M, Storer BE, Storb R, Martin PJ, Heimfeld S, Peffer A, Maloney DG, Deeg HJ, Sandmaier BM, Appelbaum FR et al..  2010.  Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.. Blood. 115(6):1288-95. Abstract
Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem H-P, Petersdorf EW, Pereira S, Nash RA, Mielcarek M, Fero ML et al..  2011.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.. Blood. 117(11):3214-9. Abstract
Mielcarek M, Storer BE, Boeckh MJ, Carpenter PA, McDonald GB, Deeg HJ, Nash RA, Flowers MED, Doney K, Lee SJ et al..  2009.  Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.. Blood. 113(13):2888-94. Abstract
Walter EC, Orozco-Levi M, Ramirez-Sarmiento A, Vigorito A, Campregher PV, Martin PJ, Flowers MED, Chien JW.  2010.  Lung function and long-term complications after allogeneic hematopoietic cell transplant.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(1):53-61. Abstract
Majhail NS, Flowers MED, Ness KK, Jagasia M, Carpenter PA, Arora M, Arai S, Johnston L, Martin PJ, Baker KS et al..  2009.  High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.. Bone marrow transplantation. 43(1):49-54. Abstract
Mossallam GI, Kamel AM, Storer BE, Martin PJ.  2009.  Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(3):352-9. Abstract
Lee S, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L et al..  2011.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1114-20. Abstract
Khera N, Chow EJ, Leisenring WM, Syrjala KL, Baker KS, Flowers MED, Martin PJ, Lee SJ.  2011.  Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(7):995-1003. Abstract
Landgren O, Gilbert ES, Rizzo DJ, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB et al..  2009.  Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.. Blood. 113(20):4992-5001. Abstract
Grogan BM, Tabellini L, Storer BE, Bumgarner TE, Astigarraga CC, Flowers MED, Lee SJ, Martin PJ, Warren EH, Hansen JA.  2011.  Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1121-32. Abstract
Rotta M, Storer BE, Storb R, Martin PJ, Flowers MED, Vernon MS, Peffer A, Maloney DG, Deeg HJ, Sandmaier BM et al..  2010.  Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(10):1463-6. Abstract
Woolfrey AE, Lee SJ, Gooley TA, Malkki M, Martin PJ, Pagel JM, Hansen JA, Petersdorf EW.  2010.  HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(10):1382-7. Abstract
Chow EJ, Mueller BA, Baker KS, Cushing-Haugen KL, Flowers MED, Martin PJ, Friedman DL, Lee SJ.  2011.  Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation.. Annals of internal medicine. 155(1):21-32. Abstract
Gooley TA, Chien JW, Pergam SA, Hingorani SR, Sorror ML, Boeckh MJ, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR et al..  2010.  Reduced mortality after allogeneic hematopoietic-cell transplantation.. The New England journal of medicine. 363(22):2091-101. Abstract
Furlong T, Martin PJ, Flowers MED, Carnevale-Schianca F, Yatscoff R, Chauncey TR, Appelbaum FR, Deeg HJ, Doney K, Witherspoon RP et al..  2009.  Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.. Bone marrow transplantation. 44(11):739-48. Abstract
Inamoto Y, Flowers MED, Lee SJ, Carpenter PA, Warren EH, Deeg HJ, Storb R, Appelbaum FR, Storer BE, Martin PJ.  2011.  Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation.. Blood. 118(2):456-63. Abstract
Whole-Body Irradiation
Mielcarek M, Martin PJ, Leisenring W, Flowers MED, Maloney DG, Sandmaier BM, Maris MB, Storb R.  2003.  Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.. Blood. 102(2):756-62. Abstract
Pagel JM, Gooley TA, Rajendran J, Fisher DR, Wilson WA, Sandmaier BM, Matthews DC, Deeg HJ, Gopal AK, Martin PJ et al..  2009.  Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.. Blood. 114(27):5444-53. Abstract
Chow EJ, Mueller BA, Baker KS, Cushing-Haugen KL, Flowers MED, Martin PJ, Friedman DL, Lee SJ.  2011.  Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation.. Annals of internal medicine. 155(1):21-32. Abstract
Mielcarek M, Burroughs L, Leisenring W, Diaconescu R, Martin PJ, Sandmaier BM, Maloney DG, Maris MB, Chauncey TR, Shizuru JA et al..  2005.  Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.. British journal of haematology. 129(3):381-91. Abstract
Water-Electrolyte Imbalance
Sangiolo D, Storb R, Deeg HJ, Flowers MED, Martin PJ, Sandmaier BM, Kiem H-P, Nash RA, Doney K, Leisenring WM et al..  2010.  Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(10):1411-8. Abstract
Washington
Mielcarek M, Storer BE, Sandmaier BM, Sorror ML, Maloney DG, Petersdorf E, Martin PJ, Storb R.  2007.  Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(12):1499-507. Abstract
Mielcarek M, Storer BE, Flowers MED, Storb R, Sandmaier BM, Martin PJ.  2007.  Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(10):1160-8. Abstract